Nafdac Pharmacovigilance/Post-Marketing Newsletter

pharmacovigilance/post-marketing newsletter Vol 1. No. 1, May 2007

When the present NAFDAC management came on board in April 2001, the Agency recognized the absence of safety monitoring system as a big setback to, not only, detecting and preventing Adverse Drug Reaction (ADR) but other vital tools to regulatory decision-making. As a result, the Agency critically examined the past experiences on the attempt to establish Pharmacovigilance and effected necessary strategies through sheer commitment and determination Click for more...

CORPORATE LINKS